LANDCAP 2: Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia (clinicaltrials.gov) - Sep 26, 2026 - P2/3 | N=460 | Not yet recruiting | Sponsor: Copenhagen Respiratory Research
Head-to-Head • New P2/3 trial • Infectious Disease • Pneumonia • Respiratory Diseases • CRP
|